❌

Normal view

Received today — 7 October 2026 ⏭ Nature Biomedical Engineering

Metal–organic framework nanovaccines for systemic tumour regression

Nature Biomedical Engineering, Published online: 06 October 2026; doi:10.1038/s41551-026-01786-5

A nanoscale metal–organic framework (MOF)-based cancer vaccine platform enables coordinated antigen presentation and innate immune activation, resulting in tumour regression, immune memory and protection against metastasis.
❌